Free Trial

Nuvation Bio (NUVB) News Today

Nuvation Bio logo
$2.30
+0.09 (+4.07%)
(As of 11/1/2024 ET)
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Sees Unusually-High Trading Volume - Time to Buy?
Nuvation Bio (NYSE:NUVB) Sees Strong Trading Volume - Should You Buy?
Nuvation Bio (NYSE:NUVB) Shares Down 4.3% - What's Next?
Nuvation Bio Inc. stock logo
Nuvation Bio Inc. (NYSE:NUVB) Short Interest Update
Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 9,970,000 shares, a drop of 53.5% from the September 30th total of 21,420,000 shares. Approximately 4.4% of the company's shares are short sold. Based on an average daily trading volume, of 1,520,000 shares, the short-interest ratio is currently 6.6 days.
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3% - What's Next?
Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3% - What's Next?
Wedbush Issues Optimistic Forecast for Nuvation Bio Earnings
Nuvation Bio Inc. stock logo
Wedbush Has Positive Outlook for Nuvation Bio Q3 Earnings
Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush boosted their Q3 2024 EPS estimates for shares of Nuvation Bio in a research note issued on Tuesday, October 22nd. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.12) per share for the quarte
FY2028 Earnings Estimate for Nuvation Bio Issued By Wedbush
Nuvation Bio Inc. stock logo
FY2028 Earnings Forecast for Nuvation Bio Issued By Wedbush
Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Wedbush issued their FY2028 earnings estimates for shares of Nuvation Bio in a report issued on Tuesday, October 22nd. Wedbush analyst D. Nierengarten anticipates that the company will earn ($0.01) per share for the year. Wedbush has a "Outperform" r
Nuvation Bio (NYSE:NUVB) Stock Rating Reaffirmed by Wedbush
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from Wedbush
Wedbush reaffirmed an "outperform" rating and set a $5.00 price target on shares of Nuvation Bio in a research note on Tuesday.
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.8% - Time to Sell?
Nuvation Bio (NYSE:NUVB) Shares Down 5.8% - What's Next?
Robert Mashal At Nuvation Bio Tops Up Holding By US$220k
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Stock Price Up 10.4% Following Insider Buying Activity
Nuvation Bio (NYSE:NUVB) Stock Price Up 10.4% Following Insider Buying Activity
Nuvation Bio Inc. stock logo
Nuvation Bio Inc. (NYSE:NUVB) Shares Purchased by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP raised its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 415.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,018,329 shares of the company's stock after acquiring
Nuvation Bio Inc. stock logo
Insider Buying: Nuvation Bio Inc. (NYSE:NUVB) Director Acquires 100,000 Shares of Stock
Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) Director Robert Mashal purchased 100,000 shares of the company's stock in a transaction that occurred on Tuesday, October 8th. The shares were purchased at an average price of $2.20 per share, for a total transaction of $220,000.00. Following the transaction, the director now owns 100,000 shares of the company's stock, valued at $220,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.4% - Here's What Happened
Nuvation Bio (NYSE:NUVB) Shares Down 5.4% - What's Next?
Nuvation Bio Inc. stock logo
Algert Global LLC Acquires 314,635 Shares of Nuvation Bio Inc. (NYSE:NUVB)
Algert Global LLC lifted its holdings in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 281.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 426,603 shares of the company's stock after acquiring an additiona
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Shares Up 4.1%
Nuvation Bio (NYSE:NUVB) Shares Up 4.1%
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Shares Down 4.3%
Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3%
BioAge Labs Inc.
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Trading Down 2.6%
Nuvation Bio (NYSE:NUVB) Shares Down 2.6%
Nuvation Bio Inc. stock logo
Equities Analysts Issue Forecasts for Nuvation Bio Inc.'s Q3 2024 Earnings (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Research analysts at HC Wainwright decreased their Q3 2024 EPS estimates for shares of Nuvation Bio in a research note issued on Monday, September 16th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($
Jefferies Releases a Buy Rating on Nuvation Bio (NUVB)
Nuvation Bio Inc. stock logo
Acadian Asset Management LLC Has $1.91 Million Position in Nuvation Bio Inc. (NYSE:NUVB)
Acadian Asset Management LLC lessened its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 44.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 653,184 shares of the company's stock after selling 521,280 shares durin
Nuvation Bio (NUVB) Receives a Buy from Wedbush
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Given Outperform Rating at Wedbush
Wedbush reaffirmed an "outperform" rating and issued a $5.00 price objective on shares of Nuvation Bio in a report on Wednesday.
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Trading 8.6% Higher
Nuvation Bio (NYSE:NUVB) Trading 8.6% Higher
Nuvation Bio Inc. stock logo
Panagora Asset Management Inc. Buys 421,563 Shares of Nuvation Bio Inc. (NYSE:NUVB)
Panagora Asset Management Inc. grew its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 198.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 633,676 shares of the company's stock after buying an additio
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Trading 4.5% Higher
Nuvation Bio (NYSE:NUVB) Stock Price Up 4.5%
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Trading Down 3.1%
Nuvation Bio (NYSE:NUVB) Trading Down 3.1%
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Stock Price Up 5.2%
Nuvation Bio (NYSE:NUVB) Stock Price Up 5.2%
Nuvation Bio Inc. stock logo
Vanguard Group Inc. Boosts Stake in Nuvation Bio Inc. (NYSE:NUVB)
Vanguard Group Inc. raised its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,534,148 shares of the company's stock after buying an additiona
Nuvation Bio Inc. stock logo
Nuvation Bio (NYSE:NUVB) Posts Earnings Results
Nuvation Bio (NYSE:NUVB - Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.09). The business had revenue of $1.44 million for the quarter.
Nuvation Bio Inc. stock logo
Royal Bank of Canada Reaffirms "Outperform" Rating for Nuvation Bio (NYSE:NUVB)
Royal Bank of Canada reaffirmed an "outperform" rating and set a $5.00 price target on shares of Nuvation Bio in a research report on Tuesday.
Get Nuvation Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

NUVB Media Mentions By Week

NUVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NUVB
News Sentiment

0.77

0.43

Average
Medical
News Sentiment

NUVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NUVB Articles
This Week

3

2

NUVB Articles
Average Week

Get Nuvation Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:NUVB) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners